MedPath
NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Capsules

国药准字H52020179

November 14, 2019

Drug Information

复方氨酚烷胺胶囊

胶囊剂

对乙酰氨基酚0.25g、盐酸金刚烷胺0.1g。

化学药品

November 14, 2019

Company Information

Manufacturing Company

贵州省贵阳市修文县扎佐医药工业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨酚烷胺胶囊 - NMPA 批准文号 | MedPath